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a b s t r a c t 
Background: Our overall objective is to develop a single-stage in- 
theatre skin replacement by combining small explants of skin with 
a synthetic biodegradable dermal scaffold. The aim of the cur- 
rent study is to determine the concentration of fibrin constituents 
and their handling properties for both adhering skin explants 
to the scaffold and encouraging cellular outgrowth to achieve 
reepithelialization. 
Methods: Small skin explants were combined with several concen- 
trations of thrombin (2.5,4.5,and 6.5 I.U) and fibrinogen (18.75,67, 
and 86.5 mg/ml), cultured in Green’s media for 14 days and 
cellular outgrowth was measured using Rose Bengal staining. They 
were also cultured on electrospun scaffolds for 14 and 21 days. 
Hematoxylin and eosin (H&E) staining was undertaken to visualize 
the interface between skin explants and scaffolds and metabolic 
activity and collagen production were assessed. 
Results: A thrombin/fibrinogen combination of 2.5 I. U/ml 
/18.75 mg/ml showed significantly greater cell viability as assessed 
by Rose Bengal stained areas at days 7 and 14. This was also seen 
in DAPI images and H&E stains skin explant/scaffold constructs. 
Fibrin with a concentration of thrombin 2.5 I.U./ml took 5–6 min 
✩ This work was presented at the British Burns Association Meeting, Swansea Apr 11–13th 2018. 
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to set, which is convenient for distributing skin explants on the 
scaffold. 
Conclusion: The study identified concentrations of thrombin 
(2.5 I.U/ml) and fibrinogen (18.75 mg/ml), which were easy to han- 
dle and aided the retention of skin explants and permitted cell out- 
growth from explants. 
© 2020 The Author(s). Published by Elsevier Ltd on behalf of 
British Association of Plastic, Reconstructive and Aesthetic 
Surgeons. 
This is an open access article under the CC BY-NC-ND license. 
( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) 
Introduction 
While the development of tissue-engineered skin to provide barrier cover has made significant 
advances since the early 1980s 1 there has been little adoption into routine clinical practice. Tissue- 
engineered skin substitutes require a dermal analogue and a cell source to populate it, consisting of 
autologous keratinocytes and fibroblasts. However, infrastructure costs (clean room facilities approved 
by Regulatory authorities and specialist cell culture staff) and production time (up to 3 weeks) have 
made adoption into routine clinical practice challenging. 
To overcome this, we proposed a one-step in-theatre approach, using small squares of split thick- 
ness skin (STS) (called skin explants) as the cell source instead of isolated cells combined with an 
electrospun scaffold to act as a neodermis for skin replacement 2 . 
The use of skin explants follows the principle of Meek grafting, which uses small squares of STS 
laid on excised wound beds in a predetermined expansion ratio for reepithelization. 
Our dermal analogue is a templated trilayer electrospun scaffold made from Poly (D, L -lactide-co- 
glycolide) lactide: glycolide 75:25 (PLGA) and Polyhydroxybutyrate/Polyhydroxyvalerate (PHBV). The 
polymers used and the design of scaffolds mimic the microstructure of human skin and have been 
shown to be suitable for skin cell migration 2–4 . The upper and bottom layers of PLGA (75:25) facili- 
tate cell migration from explants, ingrowth of fibroblasts, and collagen deposition on the wound bed, 
respectively. A templated PHBV middle layer mimics the rete ridges found between the epidermis and 
dermis. 
Our initial study revealed that skin cells migrated from the cut edge of skin explants that are 
in contact with scaffold, but not within a suitable period for sustainable clinical translation (ideally 
2–3 weeks). We also lost explants that failed to adhere to scaffolds. Failure to reepithelialize within 
a timely manner can lead to unpredictable and unfavorable scarring. Therefore, we hypothesized to 
optimize cellular migration, constant contact between skin explants and scaffolds that are required to 
be maintained throughout the culture period. 
We proposed the use of fibrin to aid the adherence of skin explants onto the scaffold. The use of 
fibrin has previously been used in our laboratory to aid the retention of corneal explants on a human 
amniotic carrier for corneal regeneration 5 . This technique called simple limbal epithelial transplanta- 
tion (SLET) has been clinically translated and is now adopted by more than twenty centers world- 
wide 6 , 7 . 
Fibrin is a meshwork of insoluble protein fibers formed when thrombin (a serine protease) con- 
verts the soluble fibrinogen to protofibrils, which aggregate into insoluble fibrin 8 , 9 . It results in the 
release of cytokines and growth factors that promote reepithelialization, angiogenesis, and collagen 
deposition 10 . Furthermore, fibroblasts are stimulated to proliferate and produce extracellular matrix 
replacing the fibrin on the neodermis. Keratinocytes are also stimulated by the fibrin meshwork to 
detach from unaffected wound edges (in this case skin explants) and start migration 10 , 11 . The throm- 
bin concentration has a significant influence on fibrin structure 12 . Low concentrations of thrombin ( < 
1 nM, < 0.1 U/mL) produce thick, loosely woven fibrils of fibrin, while higher concentrations produce 
10 K. Sharma, A.J. Bullock and V. Giblin et al. / JPRAS Open 25 (2020) 8–17 
Table 1 
Various concentrations of fibrinogen and thrombin. 
Experiment Concentration of thrombin (I.U)/ml Concentration of fibrinogen mg/ml 
1 2.5 18.75 67 86.5 
2 4.5 18.75 67 86.5 
3 6.5 18.75 67 86.5 
relatively thinner, more tightly packed fibrils 13 . Accordingly, it is important to determine the range of 
thrombin and fibrinogen concentrations that will produce fibrin, which is easy to handle, facilitates 
adherence of skin explants on scaffolds and has a microstructure to allow for cellular migration from 
explants onto the scaffold. One such fibrin product in clinical use is TISSEEL TM (Baxter Healthcare 
Corp, Deerfield, IL, USA). This has a thrombin concentration ranging from 400 to 625 units/mL and 
a fibrinogen concentration ranging from 67 to 106 mg/mL 14 . As this is FDA approved, widely avail- 
able, and used routinely, it was felt that it would be beneficial to test its suitability in our in vitro 
constructs, as this would make clinical translation using fibrin more realistic. 
This study has two related aims: 1 to determine the optimum concentration of thrombin and fib- 
rinogen to achieve a fibrin meshwork that will allow for the adhesion of skin explants. 2 Also to facili- 
tate the outgrowth of skin cells from skin explants and to assess handling properties of thrombin and 
fibrinogen combinations with respect to the placing of skin explants on the electrospun scaffold. 
Methods 
Preparation of skin explants 
STS was obtained under a Human Tissue Authority research tissue bank licence:15/YH/0017 anony- 
mously from patients undergoing breast reconstruction using excess unwanted abdominal skin. It was 
harvested manually under sterile conditions by using a Watson knife set at 2 mm. Square pieces mea- 
suring 5 × 5 mm 2 were cut and placed in phosphate-buffered saline (PBS). They were then finely 
minced into 16–20 squares to create skin explants, which were kept in Green’s media. Green’s media 
consists of a 3:1 v/v of Dulbecco’s modified Eagle’s medium and Ham’s F12 (Sigma-Aldrich, Dorset 
UK) supplemented with 10% v/v fetal calf serum (Biosera Sussex, UK), 10 ng mL −1 epidermal growth 
factor (human recombinant - R&D systems, Biotechne, Minnesota, USA), 0.4 µg mL −1 hydrocortisone, 
1 × 10 −10 mol mL −1 cholera toxin, 1.8 × 10 −4 mol L −1 adenine, 5 µg mL −1 insulin, 2 × 10 −3 mol L −1 
glutamine, 0.625 µg mL −1 amphotericin B, 100 IU mL −1 penicillin, and 100 µg mL −1 streptomycin 
(all from Sigma Aldrich, Dorset, UK). 
Fibrin preparation 
Fibrinogen from human plasma (Sigma- Aldrich, UK) ( Table 1 ) was added to 1 ml of 0.9% sodium 
chloride (w/v) and dissolved for 4 h at 37 °C, then filter sterilized. Human thrombin (Sigma-Aldrich, 
UK; 1KU) was dissolved in 4 ml of distilled water (dH 2 O) to obtain a concentration of 250 I.U/ml 
and filter sterilized. Various concentrations were obtained by diluting the thrombin (250 IU/ml) with 
dH 2 O ( Table 1 ). 
Electrospinning of PLGA–PHBV– PLGA trilayer scaffolds 
10 wt.% PLGA (75:25) was made by dissolving PLGA (Sigma-Aldrich, Dorset, UK) in 
dichloromethane (DCM, Sigma Aldrich, Dorset, UK). 10 wt.% PHBV, 12% biopolymer solutions were 
made by dissolving PHBV (Goodfellow, Cambridge limited, Huntingdon, England) in 10 wt.% methanol 
and 80 wt.% DCM (solvent ratio 88.8: 11.1 DCM–MeOH, (Sigma Aldrich)). These solutions were loaded 
into four separate 5 ml syringes (20 ml in total) fitted with blunt-tip needles (0.6 mm ID), and loaded 
into a syringe pump (Genie Plus, Kent Scientific, Connecticut, USA). Metal templates were attached 
(using carbon conductive tape (Agar Scientific, Stanstead, UK)) to the center of an earthed 10 × 10 cm 
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copper board wrapped in aluminum foil to create the templated PHBV- that mimics the rete ridges. 
Nontemplated scaffolds simply did not have the metal template, so the PBHV layer was flat. A work- 
ing distance of 17 cm from the needle tip was used for PLGA and 10 cm for PHBV. A potential 
of + 17,0 0 0 V was applied to the needle tips (73030P, Genvolt, Shropshire UK), and a flow rate of 
40 µl min −1 per syringe was used. Trilayer membranes were electrospun by consecutively spinning 
a PHBV–PLGA bilayer as above. The bilayer was peeled off the backing foil, turned over to reveal the 
uncoated PHBV side, and reattached using autoclave tape to the aluminum foil. A final coating of PLGA 
was spun on the exposed PHBV face using the above-mentioned conditions. 
Assessment of cell outgrowth from explants onto tissue culture plastic using rose bengal staining 
STS explants in Green’s media were placed in the center of polystyrene (with a cell culture coat- 
ing (proprietary)) six well plates (Costar T , Corning, ME, USA) – referred to as tissue culture plastic to 
which varying concentrations of thrombin and fibrinogen were added ( Table 1 ). They were incubated 
at 37 °C, 5% CO 2 for 14 days. After removing culture media, 1 ml of 1% Rose Bengal (Sigma–Aldrich, 
UK) was added and incubated for 5 min at room temperature. Samples were washed with PBS to re- 
move excess Rose Bengal, and photographed against a white background to allow the quantitation of 
the stained region surrounding the explant using ImageJ (NIH, USA) data expressed as mean ± SEM. 
Statistical analysis was performed by using Graphpad Prism 7.0 and a two-sample t-test with no as- 
sumption of equal variance. 
Detection of cellular migration using fluorescence microscopy 
Constructs were fixed using 3.7% formaldehyde (Sigma-Aldrich, Dorset, UK). Media were discarded 
and constructs were washed three times with sterile PBS. To each well plate, 3.7% formaldehyde was 
added and incubated for at least 2 h at 4 °C. DAPI (4 ′ ,6-diamidino-2-phenylindole, 1 ng/ml in PBS) of 
1 ml was added to each fixed sample and incubated in the dark at 37 °C for 30 min. Samples were 
washed with PBS and imaged using an Axon ImageXpress microscope (AxonCorp, USA) at excitation 
and emission wavelengths of 360 nm and 480 nm, respectively. DAPI-stained cell nuclei adjacent to 
skin explants indicate migration. 
Culture of skin explants on trilayer electrospun scaffolds and fibrin or TISSEEL TM 
Sterilized 1.5 × 1.5 cm scaffolds were placed in a 6 well plate. To this, skin explants suspended in 
Greens media, followed by either 30 µl of fibrinogen and 30 µl of thrombin (concentrations and units 
as described) or TISSEEL TM were added and cultured for 14 and 21 days, respectively (37 °C, 5% v/v 
CO 2 ). 
Detection of cellular migration onto scaffold fibers using H&E staining 
Formalin (Sigma-Aldrich, Dorset, UK) fixed samples were embedded in OCT compound, snap frozen 
in liquid nitrogen, and 7 µm cryosections cut using a cryotome (Leica, Germany). Sections were 
washed in dH 2 O for 2 min before incubation in Harris’s Hematoxylin (Sigma Aldrich, Dorset, UK) for 
2 min. Samples were then washed in dH 2 O for 1 min, followed by incubation in Eosin Y (water based, 
Sigma Aldrich, Dorset UK) for 5 min. Samples were then rinsed with dH 2 O and mounted in glycerol 
before imaging on a light microscope. 
Assessment of metabolic activity and collagen deposition of TISSEEL TM /Skin explant constructs 
Rezazurin (5 µg/ml in PBS) was used to assess cellular viability. Media were removed from con- 
structs followed by incubation in 2.5 ml of Rezazurin for 1 h at 37 °C. Rezazurin (200 µl) was taken 
from each sample and absorbance at 570 nm measured (Bio-tek ELx800). For collagen deposition, 
2 ml of 1 mg/ml Sirius red (F3B (C.I. 35,780, Direct Red 80, Sigma–Aldrich, Dorset, UK) dissolved in 
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Figure 1. A: Templated trilayer scaffold comprising upper and lower layers of randomly arranged PLGA75:25 microfibers and a 
central templated PHBV layer. B: Photograph of templated PHBV scaffold. C: SEM image of trilayer scaffold, the same showing 
templates and strands of PGLA on the surface. D: Illustration depicting the experimental set up of scaffold with fibrin and skin 
explants on top of the fibrin. 
saturated picric acid was added to each fixed construct and shaken for 18 h at room temperature. Af- 
ter prolonged washing with PBS (no further red color was eluted), the remaining stain from scaffolds 
was eluted by incubating constructs in 500 µl of destaining solution (0.2 M NaOH/methanol (1:1)) for 
30 min. Samples (100 µl) were taken and absorbance was measured at 490 nm (Bio-tek ELx800). 
Results 
Characterization of electrospun scaffolds 
Figure 1 shows that PLGA fibers formed a random microfibrous mesh on either side of the thin- 
ner PHBV random layer to create a “trilayer” structure. The average overall thickness of scaffolds was 
0.178 (range: 0.155–0.22) mm. Pore and fiber diameters were measured for two polymers from 100 
fibers of 3 different magnifications (x 50 0, x20 0 0, and x50 0 0; n = 3). The PHBV component of scaf- 
folds consisted of randomly oriented fibers with a mean diameter of 1.89 µm ± 0.072, and pore 
size of 4.16 µm ± 0.2. PLGA layers consisted of randomly oriented fibers with a mean diameter of 
2.22 µm ± 0.074 and pore size of 8.062 µm ± 0.304. 
Detection of cellular migration through a fibrin meshwork using rose bengal staining 
Rose Bengal stains by localizing primarily in cellular nuclei and, to a lesser degree other or- 
ganelles 15 . It allowed us to measure the extent of cellular outgrowth throughout the 14-day culture 
period as the outward spread of the stain (pink against a white background) could be easily mea- 
sured as an indicator of outward cellular migration without the need to fix constructs, which would 
result in cell death 5 . Figure 2 shows a progressive increase in the Rose Bengal stained area for the 
thrombin groups 2.5 I. U /ml and 4.5 I. U/ml with all concentrations of fibrinogen from day 0 to day 
14. Constructs containing thrombin/fibrinogen 2.5 I. U /ml /18.75 mg/ml showed significantly greater 
stained areas at day 7 and 14 compared to the other two fibrinogen concentrations ( p = 0.0041 at 
day 7 and p = 0.0 0 05 at day 14) ( Figure 2 ). Constructs with a thrombin concentration of 6.5 I. U/ml 
showed a decrease in the stained area from day 7 to 14 at all fibrinogen concentrations apart from 
86.5 mg/ml, which had a small but insignificant increase compared to the other fibrinogen concentra- 
tions ( p = 0.436). 
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Figure 2. Area of Rose Bengal Staining over a 14-day culture period using constructs containing various combinations of 
thrombin (Red line = 2.5 IU/ml, blue line = 4.5 IU/ml, and green line = 6.5 IU/ml) and fibrinogen (Circle = 18.5 mg/ml, 
square = 7 mg/ml, and triangle = 86.5 mg/ml) (For interpretation of the references to colour in this figure legend, the reader 
is referred to the web version of this article.) 
Figure 3. Identification of cell outgrowth from skin explants onto tissue culture plastic with explants attached, using varying 
concentrations of thrombin and fibrinogen, and assessed using DAPI fluorescence staining to identify cells. Scale bars represent 
50 µm. 
Detection of cellular migration through a fibrin meshwork onto tissue culture plastic using fluorescence 
microscopy 
A range of thrombin and fibrinogen concentrations were examined for their effect on cellular mi- 
gration from skin explants onto tissue culture plastic. The results as shown in Figure 3 , indicate that 
cellular migration surrounding skin explants was greatest using the lowest concentration of thrombin 
and fibrinogen. The migration of skin cells seemed to decrease as the fibrinogen concentration in- 
creased with negligible migration of cells from skin explants in the other thrombin/fibrinogen group 
combinations. 
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Figure 4. H&E slides of varying combinations of thrombin and fibrinogen illustrating the resultant fibrin clots, which have 
developed between skin explants and scaffolds. Scale bars represent 50 µm. 
Table 2 
Relationship between thrombin concentration and time taken for fibrin to set. 
Thrombin concentration (I.U/ml) Time taken for fibrin clot to set (min) 
2.5 5–6 
4.5 3–5 
6.5 1–2 
TISSEEL TM :500 0.16–0.33 
The use of various concentrations of thrombin and fibrinogen to secure explants onto electrospun trilayer 
scaffolds 
A range of thrombin and fibrinogen concentrations were used to assess the ease of handling of the 
various fibrin compositions and their effect on the attachment of explants to the trilayer scaffolds. 
Figure 4 shows H&E histology from various concentrations of thrombin and fibrinogen cultured with 
skin explants on scaffolds for 21 days. Gaps between skin explants and scaffolds at higher throm- 
bin/fibrinogen concentrations were larger compared to explants incubated with lower concentrations 
of thrombin and fibrinogen. At the lowest thrombin concentration, 2.5 I.U /ml, explants were found 
to be directly attached to scaffolds, seen for all three concentrations of fibrinogen. We also wanted to 
have sufficient time to position the skin explants onto the scaffold before the fibrin sets, and a less 
dense clot is desirable as it allows explants to be spread evenly on the surface rather than clump- 
ing into a mass. As expected, the time to set was influenced by the concentration of thrombin and 
fibrinogen as summarized in Table 2 . Higher concentrations of thrombin and fibrinogen resulted in 
dense clots, which set within 1–2 min and did not allow the even spread of explants, whereas lower 
concentrations set within 5–6 min. 
K. Sharma, A.J. Bullock and V. Giblin et al. / JPRAS Open 25 (2020) 8–17 15 
Figure 5. Metabolic activity of skin explants with and without Tisseel on templated and nontemplated trilayer electrospun 
scaffolds over a 21-day period (mean ± SEM). In all cases, explants were placed on the scaffolds, which were either templated 
or nontemplated and in half of the experiments explants were kept in place using Tisseel fibrin glue. 
Figure 6. Collagen production of skin explants with and without Tisseel on templated and nontemplated trilayer electrospun 
scaffolds over a 21-day period determined by staining for collagen with Sirius red. Results shown are mean ±SEM, ( n = 3). In 
all cases, explants were placed on scaffolds, which were either templated or nontemplated and in half of the experiments ex- 
plants were kept in place using Tisseel. █ Templated Scaffolds with Tisseel, █ Nontemplated Scaffolds with Tisseel, █ Templated 
Scaffolds, and █ Nontemplated Scaffolds. 
The use of commercially available fibrin (TISSEEL TM ) to secure explants onto electrospun trilayer scaffolds 
We assessed the use of TISSEEL TM to secure skin explants onto electrospun scaffolds and cul- 
tured samples for 21 days. The metabolic activity and total collagen production of constructs with 
and without TISSEEL TM were measured at 7,14, and 21 days using Rezazurin and Sirius red, respec- 
tively. Figure 5 illustrates that constructs with TISSEEL TM were viable throughout the culture period, 
with a gradual increase in metabolic activity at 3 weeks. Samples without fibrin were shown to have 
lower metabolic activity rates throughout the culture period. The addition of TISSEEL TM to constructs 
resulted in an overall increase in collagen production compared to samples without fibrin ( Figure 6 ). 
However, TISSEEL TM in keeping with its intended use as a hemostat, set into a solid dense clot in 
under a minute. This gave little time for skin explants to be spread on scaffolds and there was a 
tendency for skin explants to clump. 
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Discussion 
Our aim was to identify a fibrin composition that could be used to adhere skin explants onto a 
synthetic dermal substitute and promote cellular outgrowth from explants. 
This idea of using tissue explants rather than cultured cells is based on the MEEK technique for 
skin expansion and on our laboratories’ experience of introducing tissue explants rather than cultured 
cells for achieving corneal regeneration 5–7 . SLET removes the need for specialized facilities and trained 
staff to culture cells for clinical use. Scar tissue is debrided from the affected eye, a limbal sample 
from the unaffected eye is minced into small explants and placed on a biodegradable human amniotic 
membrane attached to the debrided eye using fibrin. Corneal cells migrate out of the limbal explants 
to form a new cornea for 6–8 weeks and results using this technique have proven slightly better than 
using laboratory expanded corneal cells 7 . 
With respect to resurfacing a full thickness skin defect, we suggest a synthetic biodegradable scaf- 
fold as a proto-synthetic dermal substitute instead of human donor tissue. These electrospun scaffolds 
can be made in large quantities from biodegradable, FDA approved, synthetic polymers, which can be 
tailored to degrade very slowly (100% PLLA) or rapidly (50/50 PLGA) 3 and sterilized using gamma ra- 
diation, which is nontoxic 16 . We suggest these polymers are suitable for providing a synthetic dermal 
scaffold to be repopulated in situ on the patient using tissue explants. 
The use of fibrin is a logical choice to adhere explants to the scaffold but depending on the con- 
stituent concentrations of thrombin and fibrinogen, fibrin can promote or inhibit cell outgrowth. In 
this study, we wished to establish a working composition of fibrin glue to use for this purpose. Thus, 
we looked at the effect of a range of concentrations of thrombin and fibrinogen on cellular outgrowth 
from explants onto tissue culture plastic, the ease of handling of fibrin including the time taken to set 
on scaffolds and the ability of the fibrin to attach explants to scaffolds. 
The first concentration tested was based on our previous work for corneal tissue engineering 
where a 1:1 mixture of fibrinogen (18.75 mg/ml) and thrombin (2.5 IU/ml), was found to maintain 
limbal explants on the scaffold and also facilitate outward cellular migration. A wider range of throm- 
bin and fibrinogen were included based on concentrations found in commercial fibrin glue prepara- 
tions. Thrombin/fibrinogen concentrations of 2.5–6.5 IU/67–86.5 mg/ml are based on Artiss TM a fibrin 
adhesive for skin graft attachment 17 . The relatively low thrombin concentration allows up to 6 min 
to position grafts or flaps before setting. The fibrinogen concentrations that we chose (67 mg and 
86.5 mg) reflects the lower and average fibrinogen concentration of Artiss TM . 
We found that the thrombin/fibrinogen concentrations that most facilitated our requirements were 
2.5 I. U/ml /18.75 mg/ml, respectively. This resulted in the greatest cell outgrowth from skin explants 
(confirmed by Rose Bengal, DAPI, and H&E staining) and resulted in the smallest gap between skin 
explants and scaffolds. This handled well and allowed an even spread of skin explants. 
TISSEEL TM was also assessed for its ability to fix skin explants onto the electrospun scaffold 14 . 
We thought that if it proved suitable, it would make clinical translation using fibrin more realistic. 
However, it sets too quickly, and was too firm in texture, tending to clump explants preventing an 
even distribution on scaffolds. One possibility is to use TISSEEL TM kit itself but dilute the concentration 
of thrombin from 500 I.U to 2.5 I.U with normal saline. In conclusion, we have established a suitable 
fibrin composition that can be used to allow skin explants to adhere to electrospun scaffolds and 
facilitate outward cellular migration. 
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